Dutasteride intralesional microinjections in combination with oral minoxidil vs. oral minoxidil monotherapy in men with androgenetic alopecia: a retrospective analysis of 105 patients

J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e570-e572. doi: 10.1111/jdv.18066. Epub 2022 Mar 26.

Authors

C D Villarreal-Villarreal^{1

2}, E Boland-Rodriguez¹, S Rodríguez-León¹, F Le Voti², S Vano-Galvan³, R D Sinclair^{4

5}

Affiliations

¹ CEDAVI Derma Experts, Hair Restoration Unit, Monterrey, Mexico.
² Dermatology Department, Faculty of Medicine of ABC, São Paulo, Brazil.
³ Trichology Unit, Dermatology Department, Ramon y Cajal Hospital, IRYCIS, University of Alcala, Madrid, Spain.
⁴ Epworth Hospital, East Melbourne, Vic., Australia.
⁵ Sinclair Dermatology Clinical Trial Centre, East Melbourne, Vic., Australia.

PMID: 35279887
DOI: 10.1111/jdv.18066

No abstract available

Publication types

Letter

MeSH terms

Alopecia* / drug therapy
Dutasteride / therapeutic use
Humans
Male
Microinjections
Minoxidil* / therapeutic use
Retrospective Studies
Treatment Outcome

Substances

Minoxidil
Dutasteride